Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 891 results for "astrazeneca"

Pfizer's $11-Billion Buyback Plan Deflates AstraZeneca Bid Hopes
NDTV Profit

Market report: AstraZeneca slips on Pfizer buy back

Citigroup said a bid for the drugmaker was still possible despite the Pfizer Yahoo! UK and Ireland, 5 hours ago
[x]  

45 images for astrazeneca

American Banking News, 2 days ago
Bioresearch Online, 2 days ago
InvestorPlace.com, 4 days ago
Yahoo! News Australia, 22 hours ago
Pharmafocus, 1 week ago
Yahoo! News, 1 day ago
Cambridge Network, 1 week ago
One News Page United Kingdom, 1 week ago
Nordic Life Science, 1 week ago
BusinessWeek, 1 week ago
Invezz

AstraZeneca ovarian cancer drug wins European green light

LONDON, Oct 24 (Reuters) - AstraZeneca's cancer drug pipeline received a boost on Friday as European regulators recommended approval of an experimental medicine against ovarian cancer. The green light from the European Medicines Agency (EMA) for ...
 Yahoo! Finance12 hours ago AstraZeneca share price: EMA gives green light to ovarian cancer drug  Invezz7 hours ago AstraZeneca's Lynparza backed for approval by EMA committee  Pharma Letter7 hours ago AstraZeneca gets some EU encouragement for its $2B cancer hopeful  FierceBiotech9 hours ago
[x]  

Potential AstraZeneca (AZN) Trade Has 4.90% Downside Protection

After ThursdayaEUR(TM)s trading in AstraZeneca Plc (http://www.marketintelligencecenter.com/symbol/AZN"AZN) MarketIntelligenceCenter.com's patented algorithms uncovered a trade that offers a 2.35% return or 15.05% on an annualized basis (for ...
 Individual.com7 hours ago AstraZeneca (AZN) Showing Resistance Near $69.37  Individual.com1 week ago

European OK for Olaparib in Ovarian Cancer

A first-in-class drug, olaparib ( Lynparza , AstraZeneca), has been recommended for approval for use in certain patients with advanced ovarian cancer by the European Medicines Agency (EMA). This is a first step; this recommendation will now be ...
 Medscape10 hours ago News and press releases: Lynparza recommended for approval in ovarian cancer  European Medicines Agency10 hours ago Olaparib tablet shows promise in pretreated ovarian cancer  Orthopedics Today1 day ago
Reuters

Pfizer Announces It Will Buy Back $11 Billion in Shares

Pfizer Inc. The purchase of London-based AstraZeneca would have reduced New York-based Pfizer's tax bill by moving its legal address overseas and given the drugmaker a greater roster of medicines. Without an acquisition, Pfizer will have almost no ...
 BusinessWeek1 day ago Why Pfizer is Hungry for Acquisition  Applied Clinical Trials6 hours ago Market overview: Probability of AstraZeneca bid has not decreased, broker says  BullBearings13 hours ago Pfizer leaves investors guessing on intentions for Astra  Reuters2 months ago
[x]  

ASTRAZENECA : Gets EMA Marketing Approval For Lynparza Cancer Treatment

LONDON ( Alliance News ) - UK pharmaceutical company AstraZeneca PLC has received approval from the European Medicines Agency for its drug Lynparza, paving the way for the UK pharmaceutical company to start marketing the treatment to ovarian cancer ...
 4 Traders12 hours ago UPDATE: AstraZeneca Gets EMA Marketing Approval For Lynparza  TMC Net12 hours ago AstraZeneca Gets EMA Marketing Approval For Lynparza Cancer Treatment  TMC Net12 hours ago
[x]  

Astrazeneca's Olaparib treatment given thumbs up by European committee

Friday brought good news for Astrazeneca shareholders after its Olaparib treatment was recommended for marketing authorisation by a European Medicines Agency (EMA) committee. The committee for Medicinal Products for Human Use (CHMP) gave the drug ...
 BullBearings9 hours ago
[x]  

Why Have GlaxoSmithKline plc And AstraZeneca plc Followed The FTSE 100 Down?

Investors tend to turn to big blue-chip dividend payers at times of market volatility, and in times past the steady earnings of pharma giants GlaxoSmithKline (LSE: GSK) and AstraZeneca (LSE: AZN) have been a particular source of comfort when the ...
 Motley Fool UK1 day ago

ASTRAZENECA : *traders: jefferies cuts astrazeneca to 'hold'

 4 Traders1 day ago Analyst Rating Flashback: AstraZeneca Down 0.9% Since Upgraded 7 Days Ago (AZN)  Individual.com4 days ago AstraZeneca Fails to Respond: Down 0.9% Since Last Week's Upgrade  Individual.com4 days ago AstraZeneca Declining Growth Reflect Potential Signs Of Trouble  InvestoBHARAT.com2 weeks ago
Bioresearch Online

AstraZeneca Bolsters Partnership With U Of Cambridge

By Estel Grace Masangkay AstraZeneca and its global biologics R&D arm MedImmune announced four new collaborations with the University of Cambridge, all launched in an attempt to strengthen AZ's existing partnership with the University as the ...
 Bioresearch Online2 days ago AstroZeneca and University of Cambridge team up for more projects  MolecularImaging.net1 day ago AstraZeneca strengthens partnership with the University of Cambridge  European Pharmaceutical Review4 days ago AstraZeneca enters four new research collaborations with University of Cambridge  PharmaBiz6 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less